Skip to search.
 FTSE 100 Down 0.25%

Gilead Sciences Inc. (GILD)

-NasdaqGS
77.92 Down 0.25(0.32%) 30 Aug 21:00
|After Hours: : 77.99 Up 0.07 (0.09%) 00:55
Prev Close:78.17
Open:78.05
Bid:77.84 x 200
Ask:77.99 x 300
1y Target Est:105.65
Beta:0.985643
Earnings Date:25 Oct - 31 Oct (Est.)
Day's Range:77.66 - 78.39
52wk Range:77.63 - 113.31
Volume:9,174,195
Avg Vol (3m):10,225,000
Market Cap:102.83b
P/E (ttm):6.84
EPS (ttm):11.39
Div & Yield:1.88 (2.36%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.32%102.83b
GSKDown 0.57%105.39b
PFEDown 0.66%211.57b

Key Statistics

Forward P/E (1 yr):6.67
P/S (ttm):3.19
Ex-Dividend Date:14-Sep-16

Analysts

Annual EPS Est (Dec-16) :11.78
Quarterly EPS Est (Sep-16) :2.88
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):85.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback